 |
 |
 |
 |

|
 |
Hemostatic defects associated with liver disease
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Biotransformation of halothane
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Biotransformation of isoflurane
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Biotransformation of desflurane
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Characteristics of sevoflurane biotransformation
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Fluorine bound to hepatic protein after exposure to 1.5 minimum alveolar ...
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Complications of liver dysfunction and cirrhosis
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Perfusion technique for preservation of liver, kidneys, and heart
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Pathophysiology of end-stage liver disease
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Orthotopic liver transplantation
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Pathologic diagnoses in adult liver transplant recipients
|
|
|
 |
 |
 |
|
 |
 |
 |
 |

|
 |
Adult liver dissection to create reduced-size liver allografts for children
|
|
|
 |
 |
 |
|